Intracerebral Hemorrhage and Reversible Cerebral Vasoconstriction Syndrome in a Patient With COVID-19
HCA Houston Healthcare Kingwood
reversible cerebral vasoconstriction syndrome, intracerebral hemorrhage, covid-19, sars-cov-2 (severe acute respiratory syndrome coronavirus -2), convexity subarachnoid hemorrhage
Internal Medicine | Nervous System Diseases | Neurology | Virus Diseases
Neurological manifestations, such as encephalopathy, intracranial neuropathy, headache, and cognitive decline, are often presented in patients with COVID-19 infection. Since the onset of the pandemic, acute ischemic stroke associated with a hypercoagulable state caused by COVID-19 is increasingly being reported. Hemorrhagic stroke is also reported via poorly understood mechanisms. We report one of the first-ever cases of intraparenchymal hemorrhage, subarachnoid hemorrhage secondary to reversible cerebral vasoconstriction syndrome in a patient with COVID-19 infection.
Publisher or Conference
Srinivasan A, Wilson B C, Bear M, et al. Intracerebral Hemorrhage and Reversible Cerebral Vasoconstriction Syndrome in a Patient With COVID-19. Cureus. 2021;13(8):e17408. doi:10.7759/cureus.17408